DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Webb DR, Htike ZZ, Swarbrick DJ. et al
A randomized, open-label, active comparator trial assessing the effects of 26
weeks of liraglutide or sitagliptin on cardiovascular function in young obese
adults with type 2 diabetes.
Diabetes, Obesity and Metabolism 2020;
22: 1187-1196
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.